A. Panizo-santos et al., Clinico-pathologic, immunohistochemical, and TUNEL study in early cardiac allograft failure, CARDIO PATH, 9(3), 2000, pp. 153-159
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Early cardiac allograft failure (ECAF) was defined as acute allograft failu
re in the early transplant period. The aim of this study is to elucidate th
e clinicopathological and immunohistochemical characteristics and the role
of apoptosis in ECAF in nine patients. We reviewed preoperative clinical da
ta and morphological data at the time of autopsy or retransplantation. We a
lso performed TUNEL assay and immunohistochemistry to study fibronectin and
tubulin P-II. The average recipient and donor age was 48 +/- 10.3 and 28 /- 7.11 respectively. Seven patients died at a mean time of 26 hours. The r
emaining two patients underwent retransplantation and are alive. The mean c
old ischemic time was 124.1 +/- 44.5 minutes. No patient had a panel reacti
ve antibody >15% and lymphocytic crossmatch was positive in one case. All c
ases had grade 2-3 of coagulative necrosis, which correlated positively wit
h fibonectin accumulation in myocyte cytoplasm, and cytoplasmic tubulin los
s (p < 0.05). TUNEL technique showed in all cases some degree of DNA strand
breaks in cardiomyocytes. Endothelium DNA strand breaks were seen in seven
cases. Patients transplanted because of idiopathic dilated cardiomyopathy
had a significantly higher degree of DNA strand breaks in cardiomyocytes an
d endothelial cells (p = 0.03 and p = 0.02) than those transplanted because
of ischemic cardiomyopathy. These results indicate that ECAF may be caused
by ischemic reperfusion damage to the donor heart assessed by myocyte coag
ulative necrosis, fibronectin accumulation in myocytes, tubulin loss, and D
NA strand breaks of cardiomyocytes and endothelium. The use of a combinatio
n of these techniques might be appropriate in the diagnosis of ECAF in endo
myocardial biopsies when it is suspected clinically. Cardiovasc Pathol 2000
;9:153-159 (C) 2000 by Elsevier Science Inc.